{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-002344","form_type":"8-K","ticker":"MLTX","cik":"0001821586","company_name":"MoonLake Immunotherapeutics","filed_at":"2026-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.348386+00:00","generated_at":"2026-05-16T11:14:49.163460+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"MoonLake gets FDA clarity on SLK in HS; no new trials needed for BLA submission","bullets":["FDA confirms MoonLake can establish substantial evidence of effectiveness using existing VELA-1, VELA-2, and MIRA trials; no additional HS trials required.","BLA submission for Sonelokimab in HS on track for H2 2026; Investor Day set for Feb 23, 2026 to discuss FDA feedback and new data.","FDA advised including VELA-2 results in BLA to inform safety profile, regardless of role in establishing effectiveness.","Upcoming milestones: Phase 2 S-OLARIS (axSpA) Q1 2026; Phase 3 IZAR-1 (PsA) mid-2026; VELA-TEEN adolescent HS readout mid-2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-002344","json":"https://secwatch.observer/filing/0001213900-26-002344.json","markdown":"https://secwatch.observer/filing/0001213900-26-002344.md","text":"https://secwatch.observer/filing/0001213900-26-002344.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1821586/000121390026002344/0001213900-26-002344-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1821586/000121390026002344/ea0272252-8k_moonlake.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:14:49.163460+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}